皮膚リンパ腫診療ガイドライン2011年改訂版

1 2011 . 1 2 3 4 2 5. 6 7 8 9 5 10. 11 4. S zary .. 4 . 1 .. 2009 10 .. WHO World Paget Health Organization EORTC The European Or- . ganisation for Research and Treatment of Cancer, Cu- . taneous Lymphomas Task Force 1 . 2 . 2008 WHO .. ! 2 . S zary TNM ISCL The In- ternational Society for Cutaneous Lymphomas . 3 4 1 . 1 WHO-EORTC 2005 . 2 . Ann Arbor 2 WHO 2008 . TNM 5 3 ISCL S zary . 6 7 3 4 . EORTC ESMO European Society for 2007 . 2011 4 . 8 . Medical Oncology United States Cutaneous Lym- S zary TNM . 9 5 . phoma Cosortium USCLC 2007 TNM .. 1 .. 2 . 3 . 4 . 5 . 11 . 6 . 7 . 8 . 9 . 10 .. 11 . 122 6 1513-1531 2012 24 1513.

2 Kim YH, Willemze R, Pimpinelli N, et al. TNM classification system for primary cutaneous lymphomas other than myco- sis fungoides and Sezary syndrome: a proposal of the Interna- . tional Society for Cutaneous Lymphomas (ISCL) and the Cu- WHO Classification of Tumours of Haematopoietic and Lym- taneous Lymphoma Task Force of the European Organiza- phoid Tissues. Ed. Swerdlow, SH, Campo E, Harris NL, Jaffe tion of Research and Treatment of Cancer (EORTC). Blood ES, Pileri SA, Stein H, Thiele J, Vardiman JW. IARC Press, 2007; 110: 479 484. Lyon, 2008.. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues.

3 Ed. Jaffe ES, Harris NL, Stein H, Vardi- Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT. man JW. IARC Press, Lyon, 2001. Long-term outcome of 525 patients with mycosis fungoides Pathology and Genetics of Skin Tumours . Ed. LeBoit PE, and Sezary syndrome. Arch Dermatol 2003; 139: 857 866. Burg G, Weedon D, Sarasin A. IARC Press, Lyon, 2006. Whittaker SJ, Marsden JR, Spittle M, Russell Jones R. Joint British Association of Dermatologists and U. K. Cutaneous . Lymphoma Group guidelines for the management of primary Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classifica- cutaneous T-cell lymphomas.

4 Br J Dermatol 2003; 149: 1095 . tion for cutaneous lymphomas. Blood 2005; 105: 3768 3785. 1107. Jaffe ES, Harris NL, Stein H, Isaacson PG. Classification of Trautinger F, Knobler R, Willemze R, et al. EORTC consen- lymphoid neoplasms: the microscope as a tool for disease dis- sus recommendations for the treatment of mycosis fungoi- covery. Blood 2008; 112: 4384-4399. ! des Sezary syndrome. Eur J Cancer 2006; 42: 1014 1030. Burg G, Kempf W, Cozzio A, et al. WHO-EORTC classification Dummer R. Primary cutaneous lymphomas: ESMO Clinical for cutaneous lymphomas 2005: histological and molecular as- Recommendations for diagnosis, treatment and follow-up.

5 An- pects. J Cutan Pathol 2005; 32: 647 674. nals of Oncology . 2007; 18 Suppl 2: ii61 ii62. Kim EJ, Hess S, Richardson SK et al. Immunopathogenesis Kim-James HY, Heffernan MP. The diagnosis, evaluation, and and therapy of cutaneous T cell lymphoma. J Clin Invest treatment of cutaneous T-cell lymphoma Curr Prob Dermatol 2005; 115: 789 812. 2001; 13: 301 340. Pimpinelli N, Olsen EA, Santucci M, et al. Defining early my- Suzuki SY, Ito K, Ito M, Kawai K. Prognosis of 100 Japanese cosis fungoides. J Am Acad Dermatol 2005; 53: 1053 1061. patients with mycosis fungoides and S zary syndrome. J Der- Vonderheid EC, Bernengo MG, Burg G, et al.

6 Update on matol Sci . 2010 Jan; 57 (1): 37 43. erythrodermic cutaneous T-cell lymphoma: Report of the In- Agar NS, Wedgeworth E, Crichton S, et al. Survival outcomes ternational Society for Cutaneous Lymphomas. J Am Acad ! and prognostic factors in mycosis fungoides S zary sun- Dermatol 2002; 46: 95 106. drome: validation of the revised International Society for Cu- Senff NJ, Hoefnagel JJ, Jansen PM et al. Reclassification of 300 ! taneous Lymphomas European Organisation for Research primary cutaneous B-cell lymphoma according to the new and Treatment of Cancer staging proposal. J Clin Oncol , 2010.

7 WHO-EORTC classification for cutaneous lymphomas: Com- 28: 4730 9. parison with previous classifications and identification of Sawada Y, Hino R, Hama K et al. Type of skin eruption is an prognostic markers. J Clin Oncol 2007; 25: 1581 1587. independent prognostic indicator for adult T-cell leukemia ! Kodama K, Massone C, Chott A et al. Primary cutaneous lymphoma. Blood 2011; 117: 3961 3967. large B-cell lymphomas: clinicopathologic features, classifica- Suzuki R, Suzumiya J, Yamaguchi M et al. Prognostic factors tion, and prognostic factors in a large series of patients. Blood for mature natural killer (NK) cell neoplasms: aggressive NK.

8 2005; 106: 2491 2497. cell leukemia and extranodal NK cell lymphoma, nasal type. Bekkenk MW, Jansen PM, Meijer CJLM, Willemze R. CD56+ Ann Oncol 2010; 21: 1032 1040. hematological neoplasms presenting in the skin: a retrospec- Senff NJ, Willemze R. The applicability and prognostic value tive analysis of 23 new cases and 130 cases from the litera- of the new TNM classification system for primary cutaneous ture. Ann Oncol 2004; 15; 1097 1108. lymphomas other than mycosis fungoides and Sezary syn- Lymphoma Study Group of Japanese Pathologists. The World drome: results and comparison with the system used by the Health Organization classification of malignant lymphomas in Dutch Cutaneous Lymphoma Group.

9 Br J Dermatol 2007; 157: Japan: Incidence of recently recognized entities. Pathology In- 1205 1211. ternational 2000; 50: 696 702. Mycosis fungoides and the Sezary syndrome ( PDQ ): treat- ment. http: !! !cancertopics!pdq!treatment! Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the ! mycosisfungoides healthprofessional National Comprehensive Cancer Network ( NCCN ) , NCCN. staging and classification of mycosis fungoides and Sezary ! Practice Guidelines in Oncology: Mycosis Fungoides Sezary syndrome: a proposal of the International Society for Cutane- ous Lymphomas (ISCL) and the Cutaneous Lymphoma Task syndrome of the cutaneous T-cell lymphomas.

10 Http: !!www. Force of the European Organization of Research and Treat- Smith BD, Smith GL, Cooper DL, Wilson LD. The cutaneous ment of Cancer (EORTC). Blood 2007; 110: 1713 1722. B-cell lymphoma prognostic index: A novel prognostic index 1514 122 6 . 1513-1531 2012 24 . 2011 . derived from a population-based registry. J Clin Oncol 2005; EORTC 2005 1 2008 . 23: 3390 3395.. Zinzani PL, Quaglino P, Pimpinelli N et al. Prognostic factors 2 Jaffe . in primary cutaneous B-cell lymphoma: The Italian study group for cutaneous lymphoma. J Clin Oncol 2006; 24: 1376 12 . 1382. WHO 4 2008 . Clinical practice guidelines for the di.